Among the many Syrians uprooted by armed conflict are thousands of people with chronic conditions – ...
Combination of two compounds shows promise in the lab
Public health expert Richard Laing discusses how independent measurement of access programs can help ...
As he hands over the Presidency of EFPIA, Novartis CEO Joe Jimenez joins others in pledging the industry’s commitment to improving lives.
More than 300 million people live with asthma globally, and 6 million do not ...
Novartis focuses its business on three divisions with innovation power and global scale: innovative medicines, eye care and generics.
